Clinical Trials Browser

Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Lung Neoplasms, Nasopharyngeal Neoplasms, Salivary Gland Neoplasms, Esthesioneuroblastoma, Olfactory, Small Cell Lung Carcinoma

NCT02360501 2016-04-20

Combination of Docetaxel, Cisplatin, and Capecitabine (DCX) in the Treatment of Nasopharyngeal Carcinoma

Phase 2 Completed

50 enrolled

Head & Neck

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms

NCT00565448 2015-07-30

Docetaxel in Combination With Cisplatin-5-fluorouracil for the Induction Treatment of Nasopharyngeal Carcinoma in Children and Adolescents

Phase 2 Completed

75 enrolled 10 charts

Head & Neck

Nasopharyngeal Carcinoma, Carcinoma, Nasopharyngeal Neoplasms

NCT01312311 2011-03-10

Weekly Docetaxel Plus Cisplatin as the First-line Therapy for Nasopharyngeal Cancer

Phase 2 Unknown

51 enrolled

Head & Neck

Nasopharyngeal Neoplasms

NCT00436293 2010-11-17

Taxotere + Cisplatin in Nasopharyngeal Carcinoma

Phase 2 Completed

61 enrolled

Head & Neck

Nasopharyngeal Neoplasms

NCT00002901 2010-01-13

Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function

Phase 1 Completed

BreastCNSGynecologicHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Ovarian Epithelial, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Lung Neoplasms, Nasopharyngeal Neoplasms, Ovarian Neoplasms, Esthesioneuroblastoma, Olfactory

NCT00004164 2009-02-09

Combination Chemotherapy in Treating Patients With Stage IIB, Stage III, or Stage IV Cancer of the Nasopharynx

Phase 2 Unknown

Head & Neck

Head and Neck Neoplasms, Nasopharyngeal Neoplasms

Clinical Trials

JMT101 Combined With Mitoxantrone Liposome for Nasopharyngeal Cancer

Keynote-122

Clinical Target Volume Based on Disease Extension Risk Atlas and Computer-aided Delineation in Nasopharyngeal Carcinoma

Docetaxel in Treating Patients With Solid Tumors

Combination of Docetaxel, Cisplatin, and Capecitabine (DCX) in the Treatment of Nasopharyngeal Carcinoma

Docetaxel in Combination With Cisplatin-5-fluorouracil for the Induction Treatment of Nasopharyngeal Carcinoma in Children and Adolescents

Weekly Docetaxel Plus Cisplatin as the First-line Therapy for Nasopharyngeal Cancer

Taxotere + Cisplatin in Nasopharyngeal Carcinoma

Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function

Combination Chemotherapy in Treating Patients With Stage IIB, Stage III, or Stage IV Cancer of the Nasopharynx